Evidence map›Paper›PMID 27397846›Full record

ArticleHepatology (Baltimore, Md.)2016

Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation.

Shirish Paranjpe, William C Bowen, Wendy M Mars, Anne Orr, Meagan M Haynes, Marie C DeFrances, Silvia Liu, George C Tseng, Anastasia Tsagianni, George K Michalopoulos

Open access · hybridAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. [Research Advances in the Roles of High-Altitude Hypoxic Stress in Hepatocellular Carcinoma].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Distinct hepatocyte identities in liver homeostasis and regeneration.JHEP reports : innovation in hepatology · 2023
    Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shirish ParanjpeDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
William C BowenDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Wendy M MarsDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Anne OrrDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Meagan M HaynesDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Marie C DeFrancesDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Silvia LiuDepartment of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
George C TsengDepartment of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Anastasia TsagianniDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
George K MichalopoulosDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA. michalopoulosgk@upmc.edu.
University of Pittsburgh · US

Funding

Treating AT Deficiency with Drugs that Modulate the Proteostasis NetworkP01DK096990 · NIDDK · WASHINGTON UNIVERSITY · PI FOX, IRA J. · 2012 to 2023
$18.3M
NIDDK NIH HHS P01 DK096990
6 · The paper itself

Abstract

Receptor tyrosine kinases MET and epidermal growth factor receptor (EGFR) are critically involved in initiation of liver regeneration. Other cytokines and signaling molecules also participate in the early part of the process. Regeneration employs effective redundancy schemes to compensate for the missing signals. Elimination of any single extracellular signaling pathway only delays but does not abolish the process. Our present study, however, shows that combined systemic elimination of MET and EGFR signaling (MET knockout + EGFR-inhibited mice) abolishes liver regeneration, prevents restoration of liver mass, and leads to liver decompensation. MET knockout or simply EGFR-inhibited mice had distinct and signaling-specific alterations in Ser/Thr phosphorylation of mammalian target of rapamycin, AKT, extracellular signal-regulated kinases 1/2, phosphatase and tensin homolog, adenosine monophosphate-activated protein kinase α, etc. In the combined MET and EGFR signaling elimination of MET knockout + EGFR-inhibited mice, however, alterations dependent on either MET or EGFR combined to create shutdown of many programs vital to hepatocytes. These included decrease in expression of enzymes related to fatty acid metabolism, urea cycle, cell replication, and mitochondrial functions and increase in expression of glycolysis enzymes. There was, however, increased expression of genes of plasma proteins. Hepatocyte average volume decreased to 35% of control, with a proportional decrease in the dimensions of the hepatic lobules. Mice died at 15-18 days after hepatectomy with ascites, increased plasma ammonia, and very small livers.

conclusionMET and EGFR separately control many nonoverlapping signaling endpoints, allowing for compensation when only one of the signals is blocked, though the combined elimination of the signals is not tolerated; the results provide critical new information on interactive MET and EGFR signaling and the contribution of their combined absence to regeneration arrest and liver decompensation. (Hepatology 2016;64:1711-1724).

Indexed as

AnimalsErbB ReceptorsLiver FailureLiver RegenerationMaleMiceProto-Oncogene Proteins c-metSignal TransductionErbB ReceptorsProto-Oncogene Proteins c-met

Identifiers

PMID27397846
PMCPMC5074871
OpenAlexW2528937381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.